4//SEC Filing
Maderazo Alan Baer 4
Accession 0001487371-21-000069
CIK 0001487371other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:02 PM ET
Size
10.7 KB
Accession
0001487371-21-000069
Insider Transaction Report
Form 4
Maderazo Alan Baer
VP, Qual, Reg, & Clin Affairs
Transactions
- Award
Market Stock Units
2021-02-18+7,500→ 7,500 totalExercise: $0.00→ Common Stock (7,500 underlying) - Award
Common Stock
2021-02-18+22,500→ 281,786 total - Sale
Common Stock
2021-02-22$20.36/sh−290$5,904→ 281,496 total - Tax Payment
Common Stock
2021-02-18−1,820→ 259,286 total
Footnotes (4)
- [F1]The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2022 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/28/2020.
- [F3]Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
- [F4]The MSU's vest in three equal installments, on each of December 31, 2021, December 31, 2022, and December 31, 2023; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
Documents
Issuer
GenMark Diagnostics, Inc.
CIK 0001487371
Entity typeother
Related Parties
1- filerCIK 0001811984
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:02 PM ET
- Size
- 10.7 KB